View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 1 / Ipilimumab 3 - Nivolumab 240, Malignant Melanoma, adjuvant, Cycle 5-24
Protocol-ID: 1895 V1.1 (Mini), NIVO1/IPIL3 - NIVO240, Melanoma, adj., C5-24Indication(s)
- Melanoma, Malignant; ICD-10 C44.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 27.01.2023